OSBPL3 and neoplasm: Elevated ERO1A, OSBPL3 and IFI44L protein expression in tumor tissues may cause patients’ median survival time 18.83%-44.07% (ERO1A:44.07%, OSBPL3: 18.83%and IFI44L, 42.37%) shorter than patients who without.